Puma Biotechnology, Inc. Provides Earnings Guidance for the Fourth Quarter and Full Year of 2023
For the year, the company expects Net Income to be $22 million - $25 million.
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
5.02 USD | +2.87% | +0.20% | +15.94% |
1st Jan change | Capi. | |
---|---|---|
+15.94% | 242M | |
+1.51% | 42.75B | |
+49.22% | 41.61B | |
+8.57% | 41.34B | |
-12.36% | 26.59B | |
+8.92% | 25.49B | |
-25.13% | 18.12B | |
+29.17% | 12.24B | |
-3.12% | 11.76B | |
+6.35% | 11B |